Balyasny Asset Management L.P.

Position in VCEL — Vericel Corp

CIK 1218710 Chicago, IL

Position in VCEL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$15,382,817

+$15,086,467 QoQ

Shares Held

345,759

+3653.4% QoQ

Ownership

0.675%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#38

of 317 holders

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,351,657,469 across 178 Biotechnology names. VCEL ranks #48 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,382,817	345,759	+3653.4%	Shares	Sole	2026-08-14
2026-03-31	$296,350	9,212	-21.8%	Shares	Sole	2026-05-15
2025-12-31	$424,197	11,780	-42.9%	Shares	Sole	2026-02-17
2025-06-30	$878,444	20,645	+280.2%	Shares	Sole	2025-08-14
2024-12-31	$298,161	5,430	-12.0%	Shares	Sole	2025-02-14
2024-09-30	$260,809	6,173	-82.3%	Shares	Sole	2024-11-14
2024-06-30	$1,600,523	34,885	+146.1%	Shares	Sole	2024-08-14
2023-09-30	$475,145	14,175	-64.3%	Shares	Other	2023-11-14
2023-06-30	$1,491,078	39,688	+40.0%	Shares	Sole	2023-08-14
2023-03-31	$831,221	28,350	—	Shares	Other	2023-05-15
No filing history on record for this holder in this stock.